These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

723 related items for PubMed ID: 16237387

  • 1. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, Härtter S, Schreckenberger M, Stoeter P, Hiemke C, Rösch F, Wong DF, Bartenstein P.
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.
    Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C, Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G.
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):951-60. PubMed ID: 20392299
    [Abstract] [Full Text] [Related]

  • 3. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
    Kegeles LS, Slifstein M, Frankle WG, Xu X, Hackett E, Bae SA, Gonzales R, Kim JH, Alvarez B, Gil R, Laruelle M, Abi-Dargham A.
    Neuropsychopharmacology; 2008 Dec; 33(13):3111-25. PubMed ID: 18418366
    [Abstract] [Full Text] [Related]

  • 4. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
    Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, Gründer G.
    J Clin Psychopharmacol; 2008 Dec; 28(6):608-17. PubMed ID: 19011428
    [Abstract] [Full Text] [Related]

  • 5. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study.
    Bigliani V, Mulligan RS, Acton PD, Ohlsen RI, Pike VW, Ell PJ, Gacinovic S, Kerwin RW, Pilowsky LS.
    Psychopharmacology (Berl); 2000 Jun; 150(2):132-40. PubMed ID: 10907666
    [Abstract] [Full Text] [Related]

  • 6. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
    Tuppurainen H, Kuikka JT, Viinamäki H, Husso M, Tiihonen J.
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):529-37. PubMed ID: 19496999
    [Abstract] [Full Text] [Related]

  • 7. Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.
    Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY.
    Neuropsychopharmacology; 2005 Dec; 30(12):2283-9. PubMed ID: 16123775
    [Abstract] [Full Text] [Related]

  • 8. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA, Erlandsson K, Jones HM, Mulligan R, Flanagan RJ, Ell PJ, Pilowsky LS.
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [Abstract] [Full Text] [Related]

  • 9. Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.
    Gründer G, Fellows C, Janouschek H, Veselinovic T, Boy C, Bröcheler A, Kirschbaum KM, Hellmann S, Spreckelmeyer KM, Hiemke C, Rösch F, Schaefer WM, Vernaleken I.
    Am J Psychiatry; 2008 Aug; 165(8):988-95. PubMed ID: 18381901
    [Abstract] [Full Text] [Related]

  • 10. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F, Gründer G, Biziere K, Stephane M, Dogan AS, Dannals RF, Ravert H, Suri A, Bramer S, Wong DF.
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [Abstract] [Full Text] [Related]

  • 11. Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.
    Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY.
    Neuropsychopharmacology; 2006 Sep; 31(9):1991-2001. PubMed ID: 16738543
    [Abstract] [Full Text] [Related]

  • 12. Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D2 /D3 dopamine system.
    Pfeifer P, Tüscher O, Buchholz HG, Gründer G, Vernaleken I, Paulzen M, Zimmermann US, Maus S, Lieb K, Eggermann T, Fehr C, Schreckenberger M.
    Addict Biol; 2017 Sep; 22(5):1449-1458. PubMed ID: 27396374
    [Abstract] [Full Text] [Related]

  • 13. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
    Talvik M, Nordström AL, Nyberg S, Olsson H, Halldin C, Farde L.
    Am J Psychiatry; 2001 Jun; 158(6):926-30. PubMed ID: 11384901
    [Abstract] [Full Text] [Related]

  • 14. Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.
    Pickar D, Su TP, Weinberger DR, Coppola R, Malhotra AK, Knable MB, Lee KS, Gorey J, Bartko JJ, Breier A, Hsiao J.
    Am J Psychiatry; 1996 Dec; 153(12):1571-8. PubMed ID: 8942453
    [Abstract] [Full Text] [Related]

  • 15. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O, Mamo D, Ginovart N, Vitcu I, Wilson AA, Zipursky RB, Kapur S.
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [Abstract] [Full Text] [Related]

  • 16. Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET study.
    Bressan RA, Erlandsson K, Jones HM, Mulligan RS, Ell PJ, Pilowsky LS.
    J Clin Psychopharmacol; 2003 Feb; 23(1):5-14. PubMed ID: 12544369
    [Abstract] [Full Text] [Related]

  • 17. Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.
    Kegeles LS, Slifstein M, Xu X, Urban N, Thompson JL, Moadel T, Harkavy-Friedman JM, Gil R, Laruelle M, Abi-Dargham A.
    Biol Psychiatry; 2010 Oct 01; 68(7):634-41. PubMed ID: 20673873
    [Abstract] [Full Text] [Related]

  • 18. In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia.
    Xiberas X, Martinot JL, Mallet L, Artiges E, Canal M, Loc'h C, Mazière B, Paillère-Martinot ML.
    J Clin Psychopharmacol; 2001 Apr 01; 21(2):207-14. PubMed ID: 11270918
    [Abstract] [Full Text] [Related]

  • 19. Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride.
    Stone JM, Bressan RA, Erlandsson K, Ell PJ, Pilowsky LS.
    Psychopharmacology (Berl); 2005 Aug 01; 180(4):664-9. PubMed ID: 15719226
    [Abstract] [Full Text] [Related]

  • 20. Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations.
    Takano A, Suhara T, Kusumi I, Takahashi Y, Asai Y, Yasuno F, Ichimiya T, Inoue M, Sudo Y, Koyama T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan 01; 30(1):75-81. PubMed ID: 16040180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.